Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00405392
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2006-11-29
Brief Title:
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline